RVMD Revenue History: $0 (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY24	$0−100.0%	$0−100.0%	$0	$0−100.0%
FY23	$7M−7.4%	$4M−58.1%	$0−100.0%	$742K−95.2%
FY22	$8M−25.2%	$9M+4.8%	$3M+204.8%	$15M+62.1%
FY21	$10M−12.3%	$9M−13.2%	$1M−91.3%	$9M+8.1%
FY20	$12M−12.3%	$10M−18.4%	$13M+1.2%	$9M−27.6%
Share	27%	26%	17%	30%

01—History

Revenue History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

YoY changeLargest recent move+148.2%in FY19

02—Ledger

Revenue, period by period

Period	Value	Change	Source
FY2025	$0	—	10-K
FY2024	$0	−100.0%	10-K
FY2023	$11.6M	−67.3%	10-K
FY2022	$35.4M	+20.4%	10-K
FY2021	$29.4M	−31.6%	10-K
FY2020	$43.0M	−14.1%	10-K
FY2019	$50.0M	+148.2%	10-K
FY2018	$20.2M	—	10-K

03—Questions

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Revolution Medicines's current revenue?

Revolution Medicines (RVMD) annual revenue for 2025 was $0, a NaN% decline from 2024. Revolution Medicines revenue for the quarter ending December 31, 2024 was $0.

What was Revolution Medicines's revenue in 2024?

Revolution Medicines annual revenue for 2024 was $0, a 100.00% decline from 2023.

What was Revolution Medicines's revenue in 2023?

Revolution Medicines annual revenue for 2023 was $11.6M, a 67.27% decline from 2022.

Company: Revolution Medicines
Ticker: RVMD
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Revolution Medicines Revenue 2018-2025 | RVMD

Key Statistics